Allspring Global Investments Holdings, LLC

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1890906 CHARLOTTE, NC

Position in TRDA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$688,439

+$442,791 QoQ

Shares Held

93,538

+380.5% QoQ

Ownership

0.240%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#36

of 128 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 33% Shared 0% None 67%

Healthcare · as of Jun 30, 2026

Allspring Global Investments Holdings, LLC holds $767,651,533 across 75 Biotechnology names. TRDA ranks #38 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	170,829	$158,490,019
2	EXEL	Exelixis, Inc.	1,998,471	$108,736,806
3	VRTX	Vertex Pharmaceuticals Inc / Ma	140,631	$69,855,635
4	BBIO	BridgeBio Pharma, Inc.	742,547	$55,304,900
5	ASND	Ascendis Pharma A/S	178,738	$47,672,997
6	CORT	Corcept Therapeutics Inc	523,192	$45,491,543
7	REGN	Regeneron Pharmaceuticals, Inc.	69,700	$43,460,737
8	MDGL	Madrigal Pharmaceuticals, Inc.	67,668	$36,334,331

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$688,439	93,538	+380.5%	Shares	Defined	2026-08-13
2026-03-31	$245,648	19,465	+11.3%	Shares	Defined	2026-05-05
2025-12-31	$179,847	17,495	+9.8%	Shares	Defined	2026-01-15
2025-09-30	$92,423	15,935	-1.0%	Shares	Defined	2025-10-20
2025-06-30	$108,138	16,092	-5.5%	Shares	Defined	2025-07-25
2025-03-31	$153,860	17,020	+53.0%	Shares	Defined	2025-04-24
2024-12-31	$192,333	11,124	-45.8%	Shares	Defined	2025-01-29
2024-09-30	$327,925	20,521	-25.7%	Shares	Defined	2024-10-18
2024-06-30	$393,741	27,631	+87.2%	Shares	Defined	2024-07-26
2024-03-31	$209,191	14,763	+427.6%	Shares	Defined	2024-04-29
2023-12-31	$42,221	2,798	0.0%	Shares	Defined	2024-01-25
2023-09-30	$44,208	2,798	—	Shares	Defined	2023-10-27
No filing history on record for this holder in this stock.